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ABSTRACT
DNA double-stranded breaks (DSBs) are among the
most severe forms of DNA damage and responsible
for chromosomal translocations that may lead to
gene fusions. The RAD51 family plays an integral
role in preserving genome stability by homology
directed repair of DSBs. From a proteomics
screen, we recently identified SFPQ/PSF as an inter-
acting partner with the RAD51 paralogs, RAD51D,
RAD51C and XRCC2. Initially discovered as a poten-
tial RNA splicing factor, SFPQ was later shown to
have homologous recombination and non-
homologous end joining related activities and also
to bind and modulate the function of RAD51. Here,
we demonstrate that SFPQ interacts directly with
RAD51D and that deficiency of both proteins
confers a severe loss of cell viability, indicating a
synthetic lethal relationship. Surprisingly, deficiency
of SFPQ alone also leads to sister chromatid
cohesion defects and chromosome instability. In
addition, SFPQ was demonstrated to mediate
homology directed DNA repair and DNA damage
response resulting from DNA crosslinking agents,
alkylating agents and camptothecin. Taken
together, these data indicate that SFPQ association
with the RAD51 protein complex is essential for
homologous recombination repair of DNA damage
and maintaining genome integrity.
INTRODUCTION
Defective DNA damage response and repair mechanisms
are underlying causes for the increased genetic instability
and chromosomal translocations associated with the evo-
lution of cancer (1,2). Among the most deleterious lesions
encountered are DNA double-strand breaks (DSBs)
because aberrant fusions can form between breaks or
with unstable telomere ends that appear as breaks. DSBs
are primarily resolved by error-free pathways such as hom-
ologousrecombination(HR)orerror-pronepathwayssuch
as non-homologous end joining (NHEJ) (3,4). Recently, it
was demonstrated that cells with HR defects are reliant
upon NHEJ, which is responsible for the chromosome
fusions, and absence of some HR and NHEJ components
can reactivate the HR pathway (5). The mechanisms there-
fore appear to compete among themselves with the balance
varying among different cell types as well as during differ-
ent stages of the cell cycle (4).
Seven RAD51 family members form integral compo-
nents of the HR machinery and interact with one another
and as part of the ‘BRCA’ protein complex. Cells deﬁcient
in any of the genes encoding the RAD51 proteins have
extensive levels of chromosome instability and are sensitive
to complex DNA damage (6–10). The fourth member
of the family, RAD51D, plays an indispensible role
during both DNA repair and telomere maintenance
(11,12). In addition, Rad51c-deﬁcient mice are susceptible
to specialized sebaceous gland tumors (13). Germline
mutations in human RAD51C are also responsible for
breast and ovarian cancer and a Fanconi anemia-like
disorder (14,15).
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for repairing DNA damage, RAD51C–XRCC3 (CX3)
and RAD51B–RAD51C–RAD51D–XRCC2 (BCDX2)
(16,17). While the CX3 complex was suggested to play a
role in resolution of Holliday junctions (18), the BCDX2
complex was shown to preferentially bind single-strand
DNA and contribute to the strand invasion step (19).
However, interacting partners involved in modulating
the activities of these complexes remain to be identiﬁed,
which has hindered progress towards understanding the
precise mechanism of HR repair.
We recently completed a proteomic proﬁling study to
identify candidates that speciﬁcally participate with
RAD51C, RAD51D and XRCC2 protein complexes
(20). Because of the suggested associations with both
HR and NHEJ, one novel protein discovered to interact
with all three proteins was SFPQ (splicing factor proline
and glutamate-rich), which is also known as PSF
(polypyrimidine tract-binding protein-associated splicing
factor) (21,22). SFPQ was initially identiﬁed as a potential
pre-mRNA modiﬁcation protein due to its binding to the
pre-mRNA splicing factor polypyrimidine tract binding
protein (PTB) (23). Further evidence, however,
demonstrated a clear differential nuclear matrix localiza-
tion of SFPQ with the majority of the protein not
co-localizing with PTB, suggesting different roles for
SFPQ in addition to RNA splicing (24). In earlier
studies, it was demonstrated that, together with an
SFPQ paralog named NONO/p54
nrb, SFPQ bound
double-stranded DNA (dsDNA) and strongly bound
ssDNA and RNA through RNA recognition motifs
(RRMs) (25). In addition, SFPQ had DNA reannealing
and strand invasion activity that formed a D-Loop, which
is similar to an HR structural intermediate (21). Recent
evidence for a direct role in DSB repair is based upon a
direct association between the N-terminal region of SFPQ
with RAD51, which stimulated RAD51 activity (26).
Furthermore, SFPQ–NONO stabilized paired DNA
DSB ends (22), and attenuation of NONO expression
conferred a deﬁciency in DSB repair and increased radi-
ation induced chromosomal aberrations (27). Even more
recently, the SFPQ–NONO complex was shown to be re-
cruited to sites of DNA damage (28). However, there still
remains a gap in addressing the speciﬁc functions of these
related mRNA processing factors in DNA repair.
In addition to demonstrating SFPQ directly interacts
with the RAD51D protein, we report here the ﬁrst direct
cellular evidence for SFPQ being involved in
homology-directed DNA repair. Reduced SFPQ expres-
sion conferred cellular sensitivity to DNA crosslinking
and alkylating agents and reduced HR levels. SFPQ de-
pletion also led to increased chromosomal aberrations,
and quite surprisingly, SFPQ-deﬁcient cells had substan-
tial sister chromatid cohesion defects. To our knowledge,
this is the ﬁrst example of a protein involved in DNA
repair that is also responsible for maintaining
interchromatid cohesion between sister chromatids with
normally aligned centromeres. In further support of the
dual role for SFPQ during DNA repair and cohesion
maintenance, combining the SFPQ depletion with a
Rad51d deletion resulted in a lethal phenotype. This
would be expected from disrupting HR, NHEJ, and
cohesion mechanisms. These ﬁndings suggest that disrup-
tion of SFPQ activity or interaction with RAD51 proteins
may provide a novel cancer therapeutic approach to sim-
ultaneously inactivate multiple DNA repair and chromo-
some maintenance pathways.
MATERIALS AND METHODS
Cell lines, vectors and protein puriﬁcation
Mouse embryonic ﬁbroblast (MEF) cell lines M12
(Wild-type), MEFC20 (Rad51d
+/+Trp53
 / ), MEF258
(Rad51d
 / Trp53
 / ) and MEF172AG (Rad51d
 / 
Trp53
 /  HARad51d) were described earlier (11).
The H2B-GFP HeLa cell line was kindly provided
by Dr Geoffrey Wahl (Salk Institute for Biological
Studies) (29). The HeLa DRGFP cell line was derived
by stable integration of the DRGFP reporter gene
into the HeLa S3 cell line (30). Puromycin resistant
single cell derived HeLa colonies were screened by
Southern blotting for intact reporter gene integration.
The pCBASce plasmid for I-SceI expression has
been described earlier (31). To generate Sfpq expres-
sion constructs, full-length mSfpq cDNA was cloned in-
frame from pYXASC1mSFPQ (ATCC, VA, USA), into
the pET28b vector (Novagen/EMD biosciences, CA,
USA) to create pET28SFPQ(His). S-tagged
RAD51D(His)6, S-tagged RAD51C(His)6, XRCC2(His)6
and SFPQ(His)6 proteins were puriﬁed from re-
spective vectors pET32Trx–RAD51D(His), pET32Trx–
RAD51C(His), pET28XRCC2(His), and
pET28SFPQ(His) as described earlier (20). The
co-precipitation experiments were performed by mixing
equimolar concentrations of each protein followed by
pulldowns using the S-tag agarose matrix (Novagen,
EMD Biosciences, NJ, USA) as described earlier (20).
Quantitative real-time PCR
DNA-free total RNA was isolated using RNeasy mini
columns (Qiagen Inc, CA, USA) and cDNA prepared
from 1mg total RNA using Oligo(dT)20 primers
(Protoscript III RT–PCR kit, New England Biolabs,
MA, USA). Gene-speciﬁc primers were designed using
Beacon Designer version 7.51 (Biosoft International,
CA, USA). RT–PCR was performed in triplicates (iQ5
Real Time PCR detection system, Bio-Rad, CA, USA)
using IQ SYBR Green Supermix (Bio-Rad). The thermo
cycling protocol used was: 95 C for 3min, followed by
40 cycles of 95 C for 10s, and 55 C for 30s. RNA expres-
sion levels were calculated using iQ5 optical system
software using the comparative ddCt method, normalized
to the expression of GAPDH, and presented as
‘normalized fold-expression’.
siRNA knockdown of SFPQ expression
Three sets of Mission siRNA oligos (Sigma Proligo, TX,
USA) for the mouse Sfpq gene corresponding to nucleo-
tides 2147–2167 (1_Sfpq_Mm and 1_Sfpq_Mm_as duplex;
siRNA1), 1639–1657 (2_Sfpq_Mm and 2_Sfpq_Mm_as
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3_Sfpq_Mm_as duplex; siRNA3) respectively were used
for transfection. Mission siRNA oligos for the mouse
Gapdh housekeeping gene corresponding to nucleotides
1090–1108 (NM_008084|1 and NM_008084|1 AS duplex,
Sigma Proligo) was used as a negative control. siRNAs
were transfected into 6 10
4 MEF cells in 24-well plates
using the nanoparticle siRNA transfection system follow-
ing manufacturer’s protocol (N-TER, Sigma, MO, USA)
16–20h after initial plating. Human Mission siRNA
(Sigma Proligo) for hSFPQ (SASI_Hs01_00073163 and
SASI_Hs01_00073163_AS duplex) and hGAPDH
(NM_002046|1 and NM_002046|1 AS duplex) were used
similarly in HeLa cells. Universal scrambled RNA
duplexes that did not target human or mouse sequences
were used as negative controls (DS Scrambled Neg, IDT
Inc., IA, USA).
Western blot analysis
Immunoblot analysis was performed using mouse mono-
clonal anti-SFPQ antibody, goat polyclonal
anti-RAD51B, rabbit polyclonal anti-Ku70, rabbit mono-
clonal anti-RPA2, mouse anti-b-actin antibody (Abcam,
MA, USA), mouse anti-numatrin (Zymed laboratory, CA,
USA), mouse monoclonal anti-CHK1 (Cell signaling tech-
nology, MA, USA), rabbit polyclonal anti-MSH2 (Santa
Cruz, CA, USA), rabbit polyclonal anti-SMC1 (Novus
Biologicals, CO, USA) for 2h at 25 C, and goat poly-
clonal anti-NONO (Abcam) for 16h at 4 C. This was
followed by 2-h incubation with the respective
species-speciﬁc secondary-HRP conjugate (Santa Cruz)
and detection using ECL (West-Pico chemiluminescent
substrate, Thermo-Scientiﬁc, IL, USA).
Cell survival assays
A total of 3 10
3 cells per well plated on a 96-well plate
in quadruplicates, for each condition tested, were
transfected with siRNA1 as described earlier. For
MTT assays, cell viability was measured 72-h after trans-
fection by incubation with 20ml/well of 5mg/ml
MethylThiazolyldiphenyl-Tetrazolium bromide (MTT;
Sigma), followed by measurement of A595nm (DTX880,
Beckman Coulter, CA, USA). For the colony forming
assays (CFUs), the cells from each well were trypsinized
24h after transfection, plated onto two 100-mm tissue
culture dishes and grown for 7 days before counting
Giemsa stained colonies.
Treatment of cells with DNA damaging agents
MEF cell lines transfected with no siRNA or 30nM of the
siRNA were treated with DNA damaging agents 24h after
transfection. The cells were treated with MMS and
MNNG for 1h, while 6-TG treatment was carried out
for 24h and media replaced after the indicated times.
For all other agents, treatments were performed continu-
ously until medium was replenished. For MTT assays, the
medium was replaced 72h following treatments, and the
cell viability checked 7days after treatment. For CFUs,
the cells were expanded as described above 24h after treat-
ment with the DNA damaging agent. The EC50 values
were calculated from a semi-log plot ﬁtted to a non-linear
regression curve analysis using Graphpad Prism 4.0
software (Graphpad Software Inc., La Jolla, CA, USA).
Statistical signiﬁcance was determined by comparing the
logEC50 for each data set using Prism 4.0, taking into
account the standard error and conﬁdence interval of
the best-ﬁt value.
Flow cytometry
A total of 5 10
5 cells were transfected with no siRNA or
30nM of Gapdh or Sfpq siRNA in 12-well plates and
treated with MMC 24h after transfection. Floating and
attached cells were collected 72h after treatment and re-
suspended in plasma membrane permeabilization medium
containing propidium iodide (50mg/ml) (32). Cell-cycle
analyses were performed using a Beckman Coulter FC
500 cytometer for a maximum cell count of 20000 cells.
Data were quantiﬁed using ModFit LT software version
3.1 (Verity Software House, Topsham, ME).
For recombination measurements, the no siRNA or
30nM of respective siRNA transfected HeLa DRGFP
cells in 12-well plates were co-transfected 24h later with
1mg pCBASce vector using Lipofectamine plus reagent
(Invitrogen). Recombinant cells were detected using an
FC 500 ﬂow cytometer and quantitated using CXP
analysis software (Beckman Coulter).
Chromosomal analysis
Giemsa stained metaphase spreads were prepared as
described (11,33). Chromosomal aberrations were scored
from a minimum of 700 chromosomes each (n 1500)
from two independent experiments. Quantiﬁcation of the
interchromatid distance on the images was performed
across each chromosome arm using Metamorph
software for Olympus, Ver. 7.5.6.0 (Olympus, PA,
USA). A total of 1000 chromosomes were measured
from at least 20 spreads from two independent experi-
ments. For analysis of prematurely condensed chromo-
somes (PCC), cells were treated with 50nM of calyculin
A (Santa Cruz) 20min prior to harvesting. The
interchromatid distances were calculated for the bivalent
G2 phase chromosomes. A minimum of 500 chromosomes
from at least 10 chromosome spreads from two independ-
ent experiments was scored.
Statistical analysis
Calculations of the mean, SD, and SE were performed
using Microsoft Excel. Statistical analysis for comparison
of each set of experimental means was performed using
Graphpad Instat 3.0. Signiﬁcance of variance was
determined by ANOVA and post-tests performed when
the variance was signiﬁcant (P<0.05). Appropriate post
test comparisons for means were made for multiple groups
using, Bonferroni Multiple Comparisons Test, Dunnett
Multiple Comparisons Test and Tukey–Kramer Multiple
Comparisons Test. For comparison of individual data
pairs in cell-cycle experiments and viability data, paired
t-test was performed on the raw data obtained. A value of
P<0.05 was considered statistically signiﬁcant.
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SFPQ and RAD51D directly interact and have epistatic
effects on cell viability
From a high-throughput co-precipitation screen to
discover proteins that function with or regulate HR,
the major category of candidates identiﬁed were predicted
mRNA processing factors (20). Because of previous
connections with DSB repair, one particularly novel candi-
date was the SFPQ protein, and 10 SFPQ peptides
were speciﬁcally identiﬁed from the mass spectroscopy
analysis of the RAD51D co-precipitation eluates
[Supplementary Figure S1a; (20)]. To further validate
the interaction, DNA independent binding of SFPQ
with RAD51D was demonstrated (Supplementary
Figure S1b), and a co-precipitation assay was performed
using S-tag agarose beads with Escherichia coli puriﬁed
S-tagged RAD51C(His)6, S-tagged RAD51D(His)6 and
SFPQ(His)6 proteins. As a positive control,
co-precipitation of S-tagged RAD51D with the known
interacting partner XRCC2 was ﬁrst conﬁrmed.
Similarly, the S-tag agarose pulldown of RAD51D
resulted in co-precipitation of SFPQ, indicating that
SFPQ directly interacts with RAD51D (Figure 1).
However, SFPQ was not co-precipitated along
with RAD51C, indicating SFPQ and RAD51C do not
directly interact and also helped to rule out random
binding with SFPQ because of any exposed dimerization
domains. Taken together, these data suggest that SFPQ
participates with the BCDX2 complex through direct
interaction with RAD51D. Since the BCDX2 complex is
known to have a strand invasion function similar to
RAD51, SFPQ could modulate its strand invasion
activity, in addition to RAD51 (26), during homology
directed DSB repair.
To begin testing the involvement of SFPQ during HR,
knockdowns of SFPQ expression were performed in MEF
cell lines. Three different siRNA duplexes decreased Sfpq
transcript expression up to 70% compared to the control
siRNA as determined by quantitative real-time (RT) PCR
(Figure 2a). The knockdown of expression with siRNA1
was further veriﬁed at the protein level (Figure 2a and
Supplementary Figure S2a). Cells deﬁcient for RAD51
paralogs activate the p53 checkpoint response and there-
fore propagate only in absence of p53 (11,13). However,
there was no signiﬁcant effect on cell viability in Trp53-
proﬁcient nor deﬁcient MEFs at these reduced levels of
SFPQ as measured by the MTT assay (Supplementary
Figure S2b). These data suggest that if SFPQ is involved
in DSB repair, the form of unresolved damage fails to
elicit a response that activates the p53 checkpoint.
To determine whether SFPQ and RAD51D are epistat-
ic, cell viability was measured by the clonogenic and MTT
assays in MEFs proﬁcient and deﬁcient for RAD51D fol-
lowing knockdown of SFPQ expression. In the Rad51d-
deﬁcient cell line, cell viability was signiﬁcantly reduced
by 40–50% compared with the Rad51d-deﬁcient cell line
with no SFPQ deﬁciency using both assays (P<0.05)
(Figure 2b and Supplementary Figure S2b). In the
colony forming assay, the SFPQ deﬁciency alone did
confer slightly reduced cell viability, which was not signiﬁ-
cantly different from the control (P>0.05). However, to
Figure 1. SFPQ interacts directly with the RAD51D protein. (a) Schematic representations of the puriﬁed tagged-proteins used for co-precipitation.
Approximate sizes are indicated. (b) Puriﬁed S-TagRAD51D(His)6 (51D), S-TagRAD51C(His)6 (51C), SFPQ(His)6 (SFPQ) and XRCC2(His)6
(XRCC2) were analyzed by immunoblot using an anti-His antibody (Left panels, Puriﬁed protein). S-protein agarose pulldown experiments were
performed using both 51D and XRCC2 proteins (51D+XRCC2) and XRCC2 alone, and using both 51D and SFPQ proteins (51D+SFPQ), 51C
and SFPQ proteins (51C+SFPQ), and SFPQ alone. The eluted proteins, were resolved on 10% PAGE, transferred onto nitrocellulose membrane,
and immunoblotted using anti-His antibody (Right panels, S-tag agarose eluate). The sizes of molecular weight markers (kDa) are indicated on the
left of each blot.
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reduction of expression due to SFPQ depletion, protein
levels of NONO and six representative DNA repair and
signaling proteins were measured (Figure 2c). Overall ex-
pression levels were not substantially affected. There was a
small but noticeable reduction of the NONO protein
levels, but the possibility of any combinatorial inﬂuence
between SFPQ and NONO was ruled out since depletion
of NONO expression alone did not affect cell viability in
either cell line (Data not shown). In addition, SFPQ ex-
pression was not affected by the status of either Rad51d or
p53 nor by treatment of cells with the DNA crosslinking
agent mitomycin C (MMC) (Supplementary Figure S2c).
Such a combined synthetic lethal phenotype does resemble
the results observed in PARP1 deﬁcient BRCA1 or
BRCA2 negative cells as well as mismatch repair deﬁcient
Figure 2. siRNA-mediated knockdown of SFPQ confers cell lethality in the absence of RAD51D. (a) Rad51d
+/+ Trp53
 /  (Rad51d
+/+) and
Rad51d
 /  Trp53
 /  (Rad51d
 / ) MEFs were transfected with Sfpq siRNAs labeled as siRNA1, siRNA2, and siRNA3 (‘Materials and Methods’
section) and expression analyzed using quantitative real-time PCR (Top histogram) and immunoblot analysis (Bottom panels). The expression was
compared to the control with no siRNA treatment (Ctrl) after the data was normalized to GAPDH expression. ***indicates P<0.001 and error bars
indicate standard deviation of values from a representative experiment performed in triplicate. Anti-SFPQ immunoblots of whole cell extracts from
Rad51d
+/+ and Rad51d
 /  MEFs were performed 24h and 48h following treatment with the indicated concentrations of Sfpq siRNA1. b-actin was
used as the loading control. (b) Cell viability was measured using the colony forming assay in both Rad51d
+/+ Trp53
 /  (Rad51d
+/+) and Rad51d
 / 
Trp53
 /  (Rad51d
 / ) MEFs transfected with the indicated concentrations of Sfpq siRNA. Cell viability for each siRNA treatment was compared to
and reported as percentage of control cells transfected with the same concentration of control siRNA. *P<0.05, **P<0.01 and error bars indicate
standard error of means of values from at least two independent experiments performed in duplicate. (c) The protein levels of SFPQ, NONO,
RAD51B, RPA2, Ku70, MSH2, CHK1 and Numatrin (Nucleophosmin) were measured using the respective antibodies in Rad51d-proﬁcient
(Rad51d
+/+) and deﬁcient (Rad51d
 / ) cell lines 24h after transfection with the indicated concentration of Sfpq siRNA1. b-actin was used as the
loading control.
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expression (34,35). Taken together with previous reports
(21,26), these results suggest an important role for SFPQ
in combination with RAD51D for repairing DSBs and
maintaining cell viability. However, the synthetic lethality
data do suggest that in addition to their roles in DSB
repair, SFPQ or RAD51D may have independent
functions.
SFPQ promotes sister chromatid cohesion and maintains
chromosome integrity
Reduced HR activity is responsible for increasing chromo-
somal instability (36). To study potential chromosomal
defects resulting from decreased SFPQ levels, Giemsa
stained metaphase spreads from Rad51d
+/+ MEFs were
analyzed following siRNA knockdown of SFPQ expres-
sion. Surprisingly, the most striking phenotype identiﬁed
was increased interchromatid distance between sister chro-
matid arms from a mean of 2.25mm for the control to
3.24mm in SFPQ-deﬁcient cells (P<0.001) (Figure 3a).
This chromosome phenotype was also observed in
Rad51d
 /  MEFs, when SFPQ expression was reduced,
the average interchromatid distance increasing from 2.26
to 2.99mm (Supplementary Figure S3). Verifying the
increase is unique to SFPQ, interchromatid distance was
not altered by attenuating NONO (average
interchromatid distance of 2.25mm ± 0.11 SED) nor
GAPDH expression (average interchromatid distance of
2.26mm±0.01 SED). Similar results were also observed
in human HeLa cells with a signiﬁcant increase from
2.14mm (±0.01 SED) in controls and 2.17mm (±0.02
SED) in NONO-deﬁcient cells to 2.50mm (±0.02 SED)
in SFPQ-deﬁcient cells (P<0.001).
The effect of SFPQ deﬁciency on interchromatid
cohesion was further validated by analysis of bivalent
PCC in the G2 phase of cell cycle, generated by treating
MEFs with calyculin A. Even though the interchromatid
distances were more variable compared with the meta-
phase spreads, the average interchromatid distance
observed in controls was 2.28mm as compared with
3.14mm in the SFPQ deﬁcient cells (P<0.001)
(Figure 3b). In addition, SFPQ deﬁciency did not affect the
levels of the central cohesion protein, SMC1 (Figure 3a,
inset), and suggest this phenotype is not likely due to an
overall decrease in cohesion protein expression. Taken
together, these data suggest that SFPQ has a unique role
in the assembly of sister chromatid cohesion.
Reduced expression of the SMC1 or SCC3 cohesin
proteins in human cells conferred spontaneous chromatid
breaks and aberrations at low levels ( 1–2%), which
increased up to 8-fold when cells were irradiated (37,38).
However, reduction of SFPQ expression resulted in a
>5-fold increase in spontaneous chromosomal aberrations
(from 8 10
 3 to 50 10
 3/chromosome). DNA damage
deﬁcient Rad51d
 /  cells show a >10-fold increase in
spontaneous aberrations (from 8 10
 3 to 108 10
 3/
chromosome), while SFPQ deﬁciency in Rad51d
 /  cells
further increases the aberrations by about 1.8-fold to
193 10
 3/chromosome (Figure 3c). Interestingly, the
number of chromosomal and chromatid breaks increased
signiﬁcantly in double-deﬁcient cells (9.1% each) as
opposed to the single mutants (5.0 and 4.5% respectively),
while the number of spontaneous fusions remained  1%
(Figure 3c). Challenging each deﬁcient cell line with 50ng/
ml of the DNA interstrand crosslinking agent MMC
further increased chromosomal aberrations by 2.75-fold
for SFPQ deﬁciency and 3.75-fold for the Rad51d
 /  cell
line. Double deﬁcient MEFs exhibited elevated levels of
chromosomal aberrations up to 45%, an increase of
1.7-fold and 1.3-fold compared to SFPQ or RAD51D de-
ﬁcient cells respectively. The elevated chromosomal breaks
resulting from the deﬁciency of either of the two genes
results in extreme chromosomal fragmentation. This
extreme fragmentation phenotype results from unrepaired
chromosome breaks and constituted nearly two-thirds of
the aberrations identiﬁed in the double deﬁcient cells.
Taken together, these data suggest SFPQ may participate
in the sister chromatid cohesion complex and enable
strand invasion of RAD51 proteins during HR between
sister chromatid strands.
SFPQ confers resistance to DNA-crosslinking, alkylating
and DSB generating agents
To determine whether SFPQ is necessary to repair DNA
damage, Rad51d-proﬁcient and deﬁcient MEFs were
treated with representative DNA damaging agents 24h
following siRNA knockdown and cell viability measured
using the MTT assay. Reduced SFPQ expression
conferred cellular sensitivity to the DNA cross-linking
agents, MMC and cisplatin, and the methylating agents,
MMS and MNNG when compared to control Rad51d-
proﬁcient cells (Figure 4a, Table 1). Comparison of
EC50 values indicate that the sensitivity of SFPQ deﬁcient
cells is similar to Rad51d-deﬁcient cells to DNA damage
resulting from both crosslinking and alkylating agents. In
the absence of both SFPQ and RAD51D, the cellular sen-
sitivity to each of these agents was further increased by
>2-fold (Table 1); however, interpretation of this data
could be complicated due to the synthetic lethal phenotype
exhibited in SFPQ deﬁcient Rad51d
 /  cells. In support of
these ﬁndings, sensitivity to MMC and MMS induced
damage was conﬁrmed using the colony forming assay
(Figure 4b). Although the EC50 values differed because
of the inability of the MTT assay to measure cell prolif-
eration, the differences in fold sensitivity in both assays
were similar.
The topoisomerase I inhibitor camptothecin was used to
determine the effect of SFPQ deﬁciency directly on DSBs.
Camptothecin induces DSBs at replication forks by
interfering with the breakage-reunion reaction of the topo-
isomerase I enzyme (39). Both Rad51d
 /  and SFPQ de-
ﬁcient MEFs were 5- to 7.5-fold more sensitive to
camptothecin respectively, which increased to  12-fold
in the double-deﬁcient MEFs compared to control
Rad51d-profecient cells (Table 1). Differences in cellular
sensitivity between Rad51d
 /  and SFPQ deﬁcient cells to
some DNA damaging agents were identiﬁed. For example,
sensitivity of MEFs to the nucleotide analogs 6-TG, which
generates predominantly S
6-methylguanine adducts,
FdURD, a thymidylate synthase inhibitor and
Nucleic AcidsResearch, 2011, Vol.39,No. 1 137Figure 3. SFPQ deﬁciency leads to defects in sister chromatid cohesion and chromosomal integrity. (a) Giemsa stained metaphase chromosome
spreads were prepared from control or Sfpq siRNA1 treated MEFs 48h after transfection. Representative images of a normal chromosome spread
and defective chromosome spread from SFPQ deﬁcient cells are shown. The distance between the sister chromatid arms were determined for at least
1000 chromosomes of each group from two independent experiments (Representative chromosomal measurements are indicated). Histogram for the
number of chromosomes with respective interchromatid distances was plotted, with the average distance and standard error for control and
Continued
138 Nucleic Acids Research, 2011,Vol. 39,No. 1hydroxyurea (HU), a DNA replication-inhibitor, were not
affected by reduced SFPQ expression in Rad51d-proﬁcient
nor Rad51d-deﬁcient cell lines. Rad51d
 /  cells however
were 3-fold more sensitive to 6-TG and FdURD but not
to HU (Table 1). Fold sensitivities were statistically sig-
niﬁcant (P<0.01) when SFPQ-deﬁcient cells were treated
with MMC, Cisplatin, MMS, MNNG and Camptothecin.
These sensitivity proﬁles suggest that SFPQ has a role in
the HR DNA repair pathway, particularly for repairing
DSBs generated directly or due to DNA crosslinks and
methylation damage. However, some DNA repair inter-
mediates that require RAD51D for processing appear to
be SFPQ independent, suggesting RAD51D and SFPQ
have some redundant but not identical functions.
Mitomycin C induces G2M cell-cycle arrest in SFPQ-
deﬁcient cells
To ascertain the effect of SFPQ deﬁciency on cell-cycle
progression, the cellular DNA content was analyzed by
ﬂow cytometry 72h following knockdown of SFPQ ex-
pression (Figure 5a). Cells deﬁcient for SFPQ show an
8–10% decrease in the percentage of cells in the G1
phase compared with controls (P<0.05) with a small
but corresponding increase of up to 5 and 6% in the
S and G2M phases respectively (Figure 5b). Rad51d-
deﬁcient and SFPQ-Rad51d double deﬁcient cells had
similar cell-cycle proﬁles, although an increase in cell
death and aneuploidy were observed in each of these
experiments.
To determine the effect of SFPQ depletion on cell-cycle
arrest following DNA damage, MEFs were treated with
50ng/ml MMC 24h following knockdown of SFPQ ex-
pression and cell-cycle distribution analyzed after 72h.
Treatment with MMC increased the percentage of cells
in the G2M phase by 13% in SFPQ-deﬁcient MEFs and
25% in both the Rad51d-deﬁcient and the double-deﬁcient
cell lines when compared with the control (Figure 5b;
P<0.05). At this dose of MMC there was also a substan-
tial increase in the number of dead and the proportion of
aneuploid cells observed in MEFs lacking Rad51d or de-
ﬁcient in SFPQ (Figure 5a, indicated by arrows). This is
consistent with the high amount of chromosomal breaks
and fragmentation previously observed in cells deﬁcient
for either or both proteins. Therefore, reduced expression
of SFPQ and RAD51D severely affects the ability of these
cells to progress through the cell cycle following DNA
damage, leading to the accumulation of cells in the
G2M phase as well as chromosomal aneuploidy.
SFPQ is necessary for homologous repair of DSBs
To directly test the role of SFPQ during HR, SFPQ
expression was reduced in HeLa cells containing a
chromosomally integrated DRGFP recombination
reporter (HeLa DRGFP). This construct consists of two
tandem and differentially mutated GFP genes, SceGFP
and iGFP, inactivated by a stop codon containing an
I-SceI recognition sequence and by a 50 and 30 truncation
respectively (30). Expression of an I-SceI endonuclease
introduces a DSB at the SceGFP gene, and when the
break is repaired by error-free HR, using iGFP as the in-
formation donor, the SceGFP allele is converted into a
functional GFP gene. In the HeLa cells, siRNA directed
against human SFPQ decreased SFPQ protein levels by
60–70% 24h following siRNA transfection (Figure 6b,
inset). No effect on the expression of NONO using this
siRNA was observed, consistent with the siRNA not
having off-target affects. HR repair was measured by
the percentage of GFP positive cells, which is negligible
in cells without the pCBASce vector expressing the endo-
nuclease (Figure 6, No Sce-I vector). In the absence of
siRNA, HR mediated repair of the DSB generated by
the I-SceI endonuclease resulted in 0.75% GFP positive
cells (Figure 6b, No siRNA) whereas siRNA knockdown
of SFPQ reduced the frequency of recombinant cells by
2-fold (P<0.05). In addition to the no-siRNA control,
siRNA against GAPDH was used as a negative control,
which did not affect SFPQ expression levels, and did not
show signiﬁcant reduction in HR repair efﬁciency. This
assay therefore provides direct evidence that SFPQ is ne-
cessary for HR repair of DSB DNA damage.
DISCUSSION
HR is required to efﬁciently repair complex DNA damage
and maintain the integrity of the mammalian genome.
Although great strides have been made identifying and
characterizing factors involved in recognition, signaling
and processing DNA breaks, the picture is far from
complete (5,40). As part of an effort to discover new
HR factors, we recently completed a proteomics screen
for RAD51C, RAD51D and XRCC2 interacting
partners (20). One intriguing protein identiﬁed from all
three co-precipitations was the splicing-related factor,
SFPQ. Previous ﬁndings had demonstrated that the
SFPQ protein consists of an N-terminal proline glutamine
rich region that also encodes the DNA-binding domain
and two RRMs followed by a C-terminal region respon-
sible for protein interaction and nuclear localization
(41–43). SFPQ potentially plays important roles during
different stages of mRNA processing as part of the
spliceosome complex and transport (44). Additional
nuclear functions include transcriptional regulation
(45,46), DNA unwinding and relaxation (47), as well as
DNA repair (22,27,28). The work reported here demon-
strates that SFPQ is essential for HR-mediated repair of
Figure 3. Continued
SFPQKD indicated (right panel). Anti-SFPQ and anti-SMC1 (Cohesin protein) expression was veriﬁed by respective immunoblots of whole cell
extracts (Inset). b-Actin was used as loading control. (b) Giemsa stained PCC spreads were prepared from control and Sfpq siRNA1 treated MEFs
48h after transfection. A Histogram representing the number of bivalent G2 phase PCCs with respective interchromatid distances is shown.
(c) Quantiﬁcation of different chromosomal aberrations (Chromatid break/gap, fusions and chromosomal break/gap) observed in the Giemsa
stained metaphase spreads for Rad51d
+/+ and Rad51d
 /  MEFs transfected with 30nM siRNA. The percentages of aberrations from untreated
and MMC treated MEFs are indicated as labels above each bar, while the overall numbers of aberrations per chromosomes ( 10
 3) are indicated
below the graphs. Note different Y-axis scales.
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to maintain sister chromatid cohesion, and directly inter-
acts with the fourth member of the RAD51 family,
RAD51D.
Direct evidence for SFPQ being involved during
HR-mediated repair of DNA DSB damage was provided
by reduction of the gene conversion frequency in the HeLa
DRGFP cell line. The 2-fold decrease of recombinant
GFP positive cells as a result of SFPQ deﬁciency was sig-
niﬁcant, particularly since 25–30% of SFPQ expression
remained. This frequency of HR is comparable to
siRNA knockdown of the RPA2 phosphorylation
protein PP4 based upon a similar recombination assay
(48). The role of SFPQ in DNA repair was further
substantiated by the sensitivity of SFPQ deﬁcient cells to
damage caused by the DNA crosslinking and alkylating
agents, as well as camptothecin. Rad51d-deﬁcient cells
were previously reported to be most sensitive to the
crosslinking agents and alkylating agents that generate
interstrand crosslinks (ICL) leading to DSB during repli-
cation (11,49). Similar sensitivity of the SFPQ deﬁcient
cells to these agents suggests an analogous role for
SFPQ in the HR pathway. However, the lack of sensitivity
of SFPQ deﬁcient cells to DNA lesions introduced by
6-TG and FdURD differs from the Rad51d-deﬁcient cell
lines. These results suggest that the two proteins are not
completely redundant. This might be important because it
is becoming clear that repairing multiple forms of DNA
damage requires integration of multiple cellular pathways
(50–52).
Because SFPQ was predicted to be a multifunctional
protein with several nuclear functions (53), we anticipated
that SFPQ would be an essential gene. However, there was
no signiﬁcant effect conferred by the siRNA-mediated
Figure 4. Knockdown of SFPQ expression confers sensitivity to DNA damaging agents. siRNA knockdown of SFPQ expression was performed in
Rad51d
+/+ and Rad51d
 /  cells and treated 24h later with indicated concentrations of Mitomycin C (MMC) and Methyl methanesulfonate (MMS).
Cell viability was measured 7 days after drug treatment using the (a) MTT assay or (b) Colony forming assay (CFU) and plotted as percentage of
cells surviving compared to the no drug control. Error bars represent SEM from at least three independent experiments performed in quadruplicates
for the MTT assay, and at least three independent experiments performed in duplicates for CFU determination.
Table 1. Fold-sensitivity of RAD51D and SFPQ deﬁcient MEFs to
DNA damaging agents
Agent Rad51d
 /  SFPQ KD Rad51d
 / SFPQ KD
MMC 3.0 3.2 9.8
Cisplatin 1.3 1.8 4.6
MMS 1.7 1.7 4.0
MNNG 2.2 3.4 9.0
Camptothecin 4.7 7.5 12.2
6TG 3.1 1.3 2.8
FdURD 3.2 1.3 1.3
Hydroxyurea 1.4 1.1 0.9
Fold sensitivities for each DNA damaging agent were calculated from
the EC50 values obtained from the MTT assays. The EC50 values are
from a semi-log plot ﬁtted to a non-linear regression curve analysis
(‘Materials and Methods’ section), and statistical signiﬁcance was
determined by comparing the logEC50 for each agent.
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mouse ﬁbroblasts. The transient nature of siRNA
knockdown as well as low levels of protein that may still
be present cannot entirely rule out the possibility that
SFPQ might still be indispensible. Consistent with these
results, an sfpq point mutation (Whitesnake) in zebra ﬁsh
embryos did not affect cell proliferation, but increased cell
death by  2-fold (54). Surprisingly, in our experiments,
there was a signiﬁcant decrease in cell survival when SFPQ
expression was reduced in Rad51d-deﬁcient cells. We
further demonstrate that SFPQ with RAD51D directly
interact, which may lead to SFPQ modulating the
strand invasion function of the BCDX2 complex,
similar to that reported for RAD51 (26). An alternative
possibility is the synthetic lethal phenotype occurs due to
the two proteins being required for non-overlapping
mutually exclusive pathways. For example, SFPQ is
also known to interact as a heterodimer with NONO
and was reported to protect free DSB ends that occur
during NHEJ (22). Therefore, it remains a formal possi-
bility that absence of both SFPQ and RAD51D is dis-
rupting the HR and NHEJ repair pathways. However,
this is unlikely to be fully responsible for a lethal pheno-
type since, to our knowledge, HR and NHEJ double
deﬁcient cells have not been reported to confer signiﬁcant
cell death in spite of increased DNA damage and cell
proliferation defects (55). Furthermore, previous reports
suggest that loss of NHEJ confers resistance to Top1
inhibitor, Camptothecin, while SFPQ deﬁcient cells
seem to be highly sensitive to Camptothecin, consistent
with a primary role for SFPQ during HR (56).
Unexpectedly, our data demonstrate that SFPQ plays
an important role in the maintenance of sister chromatid
cohesion. A previous study showed that RAD51C
Figure 5. MMC treatment induced G2M arrest of SFPQ-deﬁcient cells. (a) Representative cell-cycle distribution data of Rad51d
+/+ and Rad51d
 / 
cell lines transfected with siRNA were analyzed 72h following MMC treatment. The proportion of cells in each cell-cycle stage (G0G1, S-phase,
G2M) is indicated. The initial peak marked as debris corresponds to dead cells, while the plateau after the G2M peak (indicated by the bold arrows)
corresponds to the aneuploid population of cells and were not included in the calculations. (b) The percentage of cells in the G1, S, and G2M phase
72h following treatment. Each cell line was transfected with no siRNA or transfected with Sfpq siRNA (Rad51d
+/+SFPQ KD Rad51d
 / SFPQ KD)
24h prior to MMC treatment. The percentages of each stage of the cell cycle were calculated using ModFit software analysis (‘Materials and
Methods’ section). Error bars indicate the SEM percentages from at least three independent experiments.
Nucleic AcidsResearch, 2011, Vol.39,No. 1 141defective CL-V4B hamster cells had more than double the
number of cells with completely separated sister chroma-
tids that are not attached to centromeres. This phenotype
was attributed to premature sister chromatid separation at
the metaphase-anaphase transition but not observed in
XRCC2, XRCC3, nor BRCA1 defective cells (57).
However, similar to the differences observed in cells deﬁ-
cient for cohesin proteins, an increase in the
interchromatid distance was observed with the chromatids
remaining attached to the centromeres in SFPQ deﬁcient
cells (37). These data suggest that RAD51D and SFPQ
have distinct functions at different cell-cycle stages to
maintain sister chromatid interaction, with SFPQ likely
playing a role during cohesion formation during
replication rather than cohesion maintenance. RAD51D
deﬁciency however does not have any effect on the
cohesion phenotype and a knockdown of SFPQ in these
Rad51d
 /  cells had a similar signiﬁcant increase in
interchromatid distance.
Reduced expression of SFPQ also signiﬁcantly increased
the number of spontaneous chromosomal aberrations. The
inability to maintain sister chromatid cohesion is known to
hinder the capacity to repair spontaneous and radiation
induced DSBs during the G2 phase in yeast (58,59).
However, the levels of spontaneous levels of chromosome
breaks are low,  1%, in human cells deﬁcient for cohesin
proteins (37,38). Keep in mind that reduction of the recom-
binant GFP positive cells due to SFPQ deﬁciency in the
Figure 6. siRNA knockdown of SFPQ reduces HR mediated repair of DSBs. (a) Representative ﬂow cytometric analyses of HeLa DRGFP cells
transfected with SFPQ siRNA, GAPDH siRNA and no siRNA followed 24h later with pSCBASce vector and no pCBASce (No Sce I vector)
control. GFP positive cells from  20000 counts are seen in the quadrant marked K1. (b) Effect of siRNA knockdown of SFPQ on
recombination-mediated repair of Sce I induced chromosomal DSB. The GFP positive cells indicate the percentage of recombination events. The
corresponding siRNA used for transfection is indicated while the HeLa DRGFP cells without the pCBASce vector (No Sce I vector) is the negative
control. The error bars indicate standard errors of values from two independent experiments performed in triplicate (**P<0.01). Anti-SFPQ and
anti-NONO western blots of whole cell extracts were used to verify reduced SFPQ expression. b-Actin was used as loading control (Inset).
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increased distance of homologous strands because the
two GFP genes are repeated in tandem. Therefore, the
increased chromosomal aberrations in SFPQ deﬁcient
cells may result from two different mechanisms being
affected, DSB DNA repair (HR and NHEJ) as well as
sister chromatid cohesion. A more recent report suggests
early and rapid recruitment of the SFPQ–NONO complex
directly to sites of DNA breaks and a delay in the repair of
the DSBs in SFPQ deﬁcient cells (28).
The importance of proteins initially implicated in
spliceosome biogenesis for repairing DNA damage and
maintaining genome stability is becoming increasingly
clear. In a recent siRNA screen to identify genes involved
in genome stabilization, an mRNA processing cluster was
the most signiﬁcantly enriched group of genes, with a
majority having a role in RNA splicing (60). RAD51C
has been attributed to maintaining genome integrity by
transduction of DNA damage signals resulting from
Chk2 activation as well as via the ATM/Chk1 pathway
(61,62). A separate large-scale screen identiﬁed targets of
ATM/ATR DNA checkpoint proteins and again dis-
covered that a large number of RNA processing and tran-
scription factors were ATM/ATR phosphorylation targets
(63). SFPQ now adds to the growing list of splicing related
factors required for HR repair that includes Pso4, Ntr1,
SPF45 and Gemin2, reported to be involved in DSB and
ICL repair as well as Holliday junction binding (64–67).
These results are also consistent with recent evidence for
transcription-associated recombination (TAR) in
mammals. TAR processes are proposed to rescue stalled
replication forks generated during S phase when replica-
tion encounters transcription processes or by replication
forks encountering eroding telomeres (68,69).
Disruptions in this pathway result in defective DNA
damage response leading to more cells progressing
through S and accumulating in G2M with increased
mutation and chromosomal aberration frequencies.
The genome instability phenotype conferred by reduced
levels of SFPQ may represent a combination of SFPQ
functions to efﬁciently repair DNA lesions and to ad-
equately form sister chromatid cohesion. The multiple
SFPQ functions in RNA processing, transport and tran-
scriptional regulation might also be contributing to this
phenotype as well as the synthetic lethality conferred by
absence of both SFPQ and RAD51D. This study therefore
provides the basis to further dissect out molecular mech-
anisms of HR and interacting pathways. Future biochem-
ical studies investigating SFPQ binding, protecting and
resolving HR intermediates will help decipher the precise
role of SFPQ during homology directed repair.
Additionally, SFPQ might prove to be a useful cancer
therapy target for inactivating multiple pathways in
chemotherapy resistant cancer cells that may already be
HR defective (70,71).
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